You searched for lung cancer | Page 46 of 172

FDA Approves Fountain Medicine’s CDx for Eli Lilly’s Retevmo to Treat Solid Tumor Patients

Posted by Andy Lundin | Oct 10, 2023 | Cancer |

The genomic profiling test is approved to identify patients with solid tumors with RET gene fusions who may benefit from Retevmo treatment.

Posted by Andy Lundin | Oct 10, 2023 | Lung Cancer |

DELFI’s blood test provides results by determining the likelihood of detecting lung cancer through low-dose CT, with an NPV of 99.7 percent.

Posted by Andy Lundin | Oct 9, 2023 | Lung Cancer |

Liquid biopsies may identify NSCLC patients undergoing immunotherapy who could benefit from treatment with additional drugs.

Posted by Andy Lundin | Oct 4, 2023 | Cancer, Company News |

EValuate Diagnostics aims to make tests that detect cancer early, and will market a system for the capture of extracellular vesicles.

Posted by Andy Lundin | Oct 2, 2023 | Lung Cancer |

A novel liquid biopsy test may determine which patients with NSCLC that has spread beyond the lungs will benefit from high-dose radiation.